Early catheter treatment for high-risk pulmonary embolism
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests whether using a catheter (a thin tube) to remove blood clots from the lungs early can help people with a severe, life-threatening pulmonary embolism. It is for patients who are in shock or have had a cardiac arrest due to a large clot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a pulmonary embolism (a blood clot in the lung) confirmed by a special CT scan.
- Your condition must be very serious, such as having a cardiac arrest or being in shock with low blood pressure despite fluids.
- Your heart's right side must show signs of strain on an ultrasound or CT scan.
- You must not have any condition that makes catheter treatment unsafe, like active bleeding or recent surgery or stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
This study follows patients in Hong Kong who are treated with catheter-based therapy for acute pulmonary embolism. It aims to understand how well this treatment works.
This trial tests three ways of using a catheter (a thin tube) to remove or break up blood clots in the lungs for people with a serious but stable type of pulmonary embolism. The goal is to find the best approach to improve recovery and reduce complications.
This study looks at how well different treatments work for a blood clot in the lung (pulmonary embolism). It includes people who are getting or have already gotten a clot-dissolving medicine or a catheter procedure to remove the clot.
This study tests a new catheter-based device that delivers clot-dissolving medicine directly to the blood clot in the lungs for people with a moderate-risk pulmonary embolism. The goal is to improve blood flow to the lungs and relieve symptoms with a lower dose of medication than standard care.
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
Hear when a new Pulmonary Embolism Acute Massive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.